Access Vascular, Inc.

Stop by and see us at Booth 323! @ins1org

📢New publication alert: Hydrophilic Biomaterial Intravenous Hydrogel Catheter for Complication Reduction in PICC and Midline Catheters, authored by Dr. Nancy Moureau in Expert Review of Medical Devices. Read here: loom.ly/F8wc0Tc

🤯 Astonishing Numbers: A single large hospital incurs an estimated $3.7 million in expenses due to only three vascular access complications as highlighted in a review by Dr. Nancy Moureau (2022). We're eager to discuss how AVI's catheters might help you with these costs.

✨We're excited for #LSIUSA24 next week! 🔵 If you're attending, be sure to check out our CEO and President, James Biggins who has been selected to present. ✨ It's not too late to register at LS-Intel.com. Hope to see you there. #AccessVascular

🌟 Top 5 Innovations in Medical Devices 🌟 1️⃣ Advanced Biomaterials 2️⃣ Smart Prosthetics 3️⃣ Wearable Health Monitors 4️⃣ 3D Bioprinting 5️⃣ Robotic Surgery Systems Visit us at accesvascularinc.com/products #HealthTechInnovation

🌟 Access Vascular's hydrophilic biomaterial technology is unlike any material available for vascular access - not a coating or an additive - it's a consistently hydrophilic material without any polyurethane and it is changing the game! To learn more: loom.ly/xDISr64

🌟 Attention Clinicians! 🌟 Are you tired of the constant battle against time and avoidable complications in vascular access? 👉 Discover how AVI devices can transform your workflow and bring a new level of efficiency to your practice. Visit us at loom.ly/xDISr64

✨We're excited for the Emerging MedTech Summit! Join us at the Waldorf Astoria in Dana Point, California, from March 18-22, 2024 where James Biggins is speaking. Connect with industry leaders and innovators in medtech. #MedTech2024 #AccessVascular #LSIEmergingMedTechSummit

Happy National IV Nurses' Day to the incredible heroes behind the needle! Today, we celebrate the skill, compassion, and dedication of IV nurses who play a vital role in patient care. We thank you for being the lifeline in healthcare! 🙌👩‍⚕️👨‍⚕️ #IVNursesDay #HealthcareHeroes

The HydroPICC is made of a hydrophilic material that does not disrupt the body’s natural chemistry, evading thrombogenic activity and the resulting complications. #evadethrombus Request follow-up on the HydroPICC: bit.ly/AccessVascular

Raising awareness on World Thrombosis Day! Our mission is to reach NO Thrombosis in vascular access procedures. We support and appreciate the front-line clinicians who #keeplifeflowing. Learn more: accessvascularinc.com/transforming

New case study by Joseph Bunch, RN, CEO, reviews a COVID-19 patient who had occlusions with two polyurethane PICC lines. Then the HydroPICC® was inserted, remaining without incident for 45 days. Read full report: accessvascularinc.com/picc-complicat… #ReinventingVenousAccess

On this Vascular Access Specialty Day, we’d like to share our appreciation for the skills, knowledge and compassion you put into your line placement. #thankyou #VASD2021 #evadethrombus @ISaveThatLine

We are hiring! Join our expanding team as we work to advance and transform vascular access with products that take the burden off healthcare providers and patients. Roles available in our Operations and Commercial teams: boards.greenhouse.io/accessvascular

Data presented at the AVA Annual Scientific Meeting shows impactful reductions in occlusions, DVT, and phlebitis using materials that mimic the body’s chemistry. Read press release: finance.yahoo.com/news/access-va… @ISaveThatLine

Join us at the virtual AVA Annual Scientific Meeting for a Product Demo Roundtable to learn how HydroPICC & HydroMID catheters keep treatment moving forward, with the presentation of clinical data*. Fri, Sept 17, 1:15-2:45pm EDT. @ISaveThatLine *accessvascularinc.com/ava2021

This partnership focuses on empowering Vascular Access specialists in their mission to reduce complications in vascular access procedures via access to advanced technologies and clinical education. Read press release: accessvascularinc.com/ava

In standard catheters, the body sees polyurethane as foreign, inciting a thrombogenic response. We’ve created a catheter composed of a consistently hydrophilic, proprietary material that doesn’t trigger a foreign body response.* *accessvascularinc.com

Thrombus takes time and resources away from providing care. AVI catheters help to move treatment forward, with average 97% reduction in thrombus accumulation* and zero occlusions or failures.** *bit.ly/AccessVascular. **Retrospective clinical study, publication pending.

Access Vascular, Inc. is hiring a Medical Device Operator grnh.se/40d1a9504us via @greenhouse